Prof. Gordon Muirhead
Visiting Professor of Pharmaceutics, Leicester School of Pharmacy
De MontFort University
He is a Pharmacist and has worked in the Pharmaceutical Industry – in senior Manufacturing, Operations, General Management and Development global roles – for over 30 years, and is a Fellow of the Royal Pharmaceutical Society (FRPharmS).
Previously, Gordon was Vice President of Global New Medicines Introduction within the Global Manufacturing and Supply division of GlaxoSmithKline (GSK). In this time GSK Filed, Launched and Transfered a significant number of new medicines, new combination medicines, and new drug-device combinations… from multiple sites into world-wide markets. Prior to this role, he was Head of Global Process Technologies within Product Development, R&D, GSK to advance Process Analytical Technologies (PAT), Quality by Design (QbD) and Secondary Continuous Processing within that company. Gordon was one of the first Senior Fellows in GSK Manufacturing, and is now the first GSK Emeritus Senior Fellow.
Gordon is also Visiting Professor of Pharmaceutics within the Leicester School of Pharmacy at De Montfort University, with a particular research interest into the practical application of a Rapid Adaptive Continuous development and commercial manufacturing platform, underpinned by QbD and PAT to accelerate Medicines development and launch.
Described as “an Engineer, trapped in the body of a Pharmacist”… Gordon is also an Associate Fellow of the Institute of Chemical Engineers (AFIChemE). He is also active in STEM initiatives, to help inspire the next generations of engineers and scientists.
An ex-professional musician, Gordon still believes he can become a famous Rock Star… and has a Recording Studio and a bank of guitars ready for that big break!
- Accelerated Medicines Development Using Adaptive Continuous Manufacturing
28 April 2020 10:00 am